{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:46:46Z","timestamp":1782467206372,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10552-026-02172-x","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:47:30Z","timestamp":1776844050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Classic psychedelic and cannabis use among U.S. cancer survivors aged\u2009\u2265\u200950\u00a0years: nationally representative estimates by cancer type\/site"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0961-9665","authenticated-orcid":false,"given":"Amrit","family":"Baral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WayWay M.","family":"Hlaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Garcia-Romeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo S.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise C.","family":"Vidot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"1","key":"2172_CR1","doi-asserted-by":"publisher","first-page":"pkae004","DOI":"10.1093\/jncics\/pkae004","volume":"8","author":"S Amin","year":"2024","unstructured":"Amin S, Chae SW, Kawamoto CT, Phillips KT, Pokhrel P (2024) Cannabis use among cancer patients and survivors in the United States: a systematic review. JNCI Cancer Spectr 8(1):pkae004","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"2172_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/imr.2024.0001","volume":"3","author":"S Nugent","year":"2024","unstructured":"Nugent S, Latour E, Lim J, Shannon J, Morasco BJ (2024) Cannabis use is associated with pain severity and interference among cancer survivors. Integr Med Rep 3(1):81\u201391","journal-title":"Integr Med Rep"},{"issue":"4","key":"2172_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/ALN.0000000000004673","volume":"139","author":"A Goel","year":"2023","unstructured":"Goel A, Rai Y, Sivadas S et al (2023) Use of psychedelics for pain: a scoping review. Anesthesiology 139(4):523\u2013536","journal-title":"Anesthesiology"},{"key":"2172_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102592","volume":"56","author":"Y Zolotov","year":"2021","unstructured":"Zolotov Y, Eshet L, Morag O (2021) Preliminary assessment of medical cannabis consumption by cancer survivors. Complement Ther Med 56:102592","journal-title":"Complement Ther Med"},{"issue":"4","key":"2172_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09540261.2018.1482261","volume":"30","author":"S Ross","year":"2018","unstructured":"Ross S (2018) Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. Int Rev Psychiatry 30(4):317\u2013330","journal-title":"Int Rev Psychiatry"},{"issue":"9","key":"2172_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1177\/10600280221144055","volume":"57","author":"CM White","year":"2023","unstructured":"White CM, Weisman N, Dalo J (2023) Psychedelics for patients with cancer: a comprehensive literature review. Ann Pharmacother 57(9):1062\u20131075","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2172_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.37349\/emed.2023.00138","volume":"4","author":"G Giordano","year":"2023","unstructured":"Giordano G, Martin-Willett R, Gibson LP et al (2023) Cannabis use in cancer patients: acute and sustained associations with pain, cognition, and quality of life. Explor Med 4(2):254\u2013271","journal-title":"Explor Med"},{"issue":"1","key":"2172_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","volume":"239","author":"N Schimmers","year":"2022","unstructured":"Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA (2022) Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review. Psychopharmacology 239(1):15\u201333","journal-title":"Psychopharmacology"},{"issue":"04","key":"2172_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1055\/a-1341-1907","volume":"54","author":"LJ Mertens","year":"2021","unstructured":"Mertens LJ, Preller KH (2021) Classical psychedelics as therapeutics in psychiatry\u2013current clinical evidence and potential therapeutic mechanisms in substance use and mood disorders. Pharmacopsychiatry 54(04):176\u2013190","journal-title":"Pharmacopsychiatry"},{"key":"2172_CR10","first-page":"959","volume-title":"Handbook of behavioral neuroscience","author":"CD Nichols","year":"2020","unstructured":"Nichols CD, Hendricks PS (2020) Classic psychedelics as therapeutics for psychiatric disorders. Handbook of behavioral neuroscience, vol 31. Elsevier, pp 959\u2013966"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"116715","DOI":"10.1016\/j.jns.2020.116715","volume":"411","author":"T Chi","year":"2020","unstructured":"Chi T, Gold JA (2020) A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. J Neurological Sci 411:116715","journal-title":"J Neurological Sci"},{"issue":"11","key":"2172_CR12","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1177\/10499091221143098","volume":"40","author":"LM Philpot","year":"2023","unstructured":"Philpot LM, Ramar P, Jatoi A, Rosedahl J, Canning R, Ebbert JO (2023) Cannabis in cancer survivors who report high impact chronic pain: findings from a 1500+ patient survey. Am J Hospice Palliat Med 40(11):1196\u20131204","journal-title":"Am J Hospice Palliat Med"},{"issue":"14","key":"2172_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143495","volume":"13","author":"M Camacho-Rivera","year":"2021","unstructured":"Camacho-Rivera M, Islam JY, Rodriguez DL, Vidot DC (2021) Cannabis use among cancer survivors amid the COVID-19 pandemic: results from the COVID-19 cannabis health study. Cancers 13(14):3495","journal-title":"Cancers"},{"issue":"2","key":"2172_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2190\/PM.40.2.c","volume":"40","author":"CB Harrington","year":"2010","unstructured":"Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It\u2019s not over when it\u2019s over: long-term symptoms in cancer survivors\u2014a systematic review. Int J Psychiatry Med 40(2):163\u2013181","journal-title":"Int J Psychiatry Med"},{"issue":"S11","key":"2172_CR15","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/cncr.23448","volume":"112","author":"KD Stein","year":"2008","unstructured":"Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long\u2010term and late effects of cancer. Cancer 112(S11):2577\u20132592","journal-title":"Cancer"},{"issue":"4","key":"2172_CR16","first-page":"283","volume":"75","author":"MJ Naughton","year":"2014","unstructured":"Naughton MJ, Weaver KE (2014) Physical and mental health among cancer survivors: considerations for long-term care and quality of life. N C Med J 75(4):283","journal-title":"N C Med J"},{"key":"2172_CR17","first-page":"361","volume-title":"Behavioral neurobiology of psychedelic drugs","author":"MP Bogenschutz","year":"2018","unstructured":"Bogenschutz MP, Ross S (2018) Therapeutic applications of classic hallucinogens. Behavioral neurobiology of psychedelic drugs. pp 361\u2013391"},{"issue":"3","key":"2172_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/acm.2011.0022","volume":"18","author":"JG Anderson","year":"2012","unstructured":"Anderson JG, Taylor AG (2012) Use of complementary therapies for cancer symptom management: results of the 2007 national health interview survey. J Altern Complement Med 18(3):235\u2013241","journal-title":"J Altern Complement Med"},{"key":"2172_CR19","doi-asserted-by":"crossref","unstructured":"Fouladbakhsh JM, Stommel M (2008) Comparative analysis of CAM use in the US cancer and noncancer populations. J Complementary Integrative Med 5(1)","DOI":"10.2202\/1553-3840.1140"},{"issue":"1","key":"2172_CR20","first-page":"71","volume":"5","author":"L VandeCreek","year":"1999","unstructured":"VandeCreek L, Rogers E, Lester J (1999) Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med 5(1):71","journal-title":"Altern Ther Health Med"},{"key":"2172_CR21","unstructured":"Backhus LM, Zeliadt SB, Reinke L, Rue T, Au DH One size does not fit all: differences in quality of life and survivorship among lung, colon, breast and prostate cancer patients"},{"issue":"3","key":"2172_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/10463356.2010.11883777","volume":"25","author":"A Patton","year":"2010","unstructured":"Patton A (2010) Anderson breast cancer survivor clinic. Oncol Issues 25(3):44\u201347","journal-title":"Oncol Issues"},{"issue":"3","key":"2172_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2016.10.020","volume":"18","author":"JA Paice","year":"2017","unstructured":"Paice JA, Mulvey M, Bennett M et al (2017) AAPT diagnostic criteria for chronic cancer pain conditions. J Pain 18(3):233\u2013246","journal-title":"J Pain"},{"issue":"2","key":"2172_CR24","doi-asserted-by":"publisher","DOI":"10.15275\/rusomj.2019.0205","volume":"8","author":"OP Bobrova","year":"2019","unstructured":"Bobrova OP, Shnayder NA, Dychno YA, Zyryanov SK, Petrova MM (2019) Chronic pain syndrome in patients with pancreatic cancer: individual therapy and its pathogenetic background. Russ Open Med J 8(2):205","journal-title":"Russ Open Med J"},{"issue":"3","key":"2172_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.61506\/01.00055","volume":"12","author":"H Perveen","year":"2023","unstructured":"Perveen H, Ayyaz S, Abbas S, Sagur MK, Ali R, Mirza MH (2023) Psychological burden of breast cancer predicted quality of life: a case study of multan institute of nuclear medicine and radiology. Bull Business Economics (BBE) 12(3):469\u2013472","journal-title":"Bull Business Economics (BBE)"},{"issue":"1","key":"2172_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clindermatol.2011.11.005","volume":"31","author":"NA Kasparian","year":"2013","unstructured":"Kasparian NA (2013) Psychological stress and melanoma: are we meeting our patients\u2019 psychological needs? Clin Dermatol 31(1):41\u201346","journal-title":"Clin Dermatol"},{"key":"2172_CR27","unstructured":"NSDUH Data Files. https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh\/datafiles. Accessed 20 November 2024"},{"key":"2172_CR28","unstructured":"2019 National Survey on Drug Use and Health (NSDUH) Methodological Resource Book. Rockville, Maryland: Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality March 2021"},{"key":"2172_CR29","unstructured":"2021 National Survey on Drug Use and Health (NSDUH) methodological resource book Section 8: Data collection final report. 2023; https:\/\/www.samhsa.gov\/data\/report\/nsduh-2021-data-collection-final-report"},{"key":"2172_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100253","volume":"12","author":"DT Mattingly","year":"2024","unstructured":"Mattingly DT, Richardson MK, Hart JL (2024) Prevalence of and trends in current cannabis use among US youth and adults, 2013\u20132022. Drug Alcohol Depend Rep 12:100253","journal-title":"Drug Alcohol Depend Rep"},{"key":"2172_CR31","unstructured":"2022 National Survey on Drug Use and Health (NSDUH) Methodological Resource Book Section 8: Data Collection Final Report. 2023; https:\/\/www.samhsa.gov\/data\/report\/nsduh-2022-methodological-resource-book-mrb. Accessed 29 October 2024"},{"issue":"4","key":"2172_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/10282580701677477","volume":"10","author":"PN Jones","year":"2007","unstructured":"Jones PN (2007) The native American church, peyote, and health: expanding consciousness for healing purposes. Contemp Justice Rev 10(4):411\u2013425","journal-title":"Contemp Justice Rev"},{"issue":"8","key":"2172_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biopsych.2005.06.038","volume":"58","author":"JH Halpern","year":"2005","unstructured":"Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG Jr (2005) Psychological and cognitive effects of long-term peyote use among native Americans. Biol Psychiatry 58(8):624\u2013631","journal-title":"Biol Psychiatry"},{"key":"2172_CR34","unstructured":"2022 National Survey on Drug Use and Health. Public Use File Codebook (2022) https:\/\/www.samhsa.gov\/data\/system\/files\/media-puf-file\/NSDUH-2022-DS0001-info-codebook.pdf. Accessed 20 November 2024"},{"key":"2172_CR35","unstructured":"Results from the 2016 National Survey on Drug Use and Health: Methodological Resource Book (Section 8, Data Collection Final Report) (2017) https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs-2016\/NSDUH-DetTabs-2016.pdf. Accessed 10 November 2024"},{"key":"2172_CR36","unstructured":"2019 National Survey on Drug Use and Health (NSDUH) Methodological Resource Book Section 13: Statistical Inference Report 2021; https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt34666\/NSDUHmrbStatInference2019.pdf. Accessed 29 October 2024"},{"issue":"24","key":"2172_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245822","volume":"15","author":"I Osaghae","year":"2023","unstructured":"Osaghae I, Chido-Amajuoyi OG, Khalifa BAA, Talluri R, Shete S (2023) Cannabis use among cancer survivors: use pattern, product type, and timing of use. Cancers 15(24):5822","journal-title":"Cancers"},{"issue":"3","key":"2172_CR38","doi-asserted-by":"publisher","DOI":"10.3747\/co.25.3983","volume":"25","author":"K Martell","year":"2018","unstructured":"Martell K, Fairchild A, LeGerrier B et al (2018) Rates of cannabis use in patients with cancer. Curr Oncol 25(3):219","journal-title":"Curr Oncol"},{"issue":"58","key":"2172_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/jncimonographs\/lgab011","volume":"2021","author":"M Sexton","year":"2021","unstructured":"Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS (2021) The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. JNCI Monogr 2021(58):86\u201398","journal-title":"JNCI Monogr"},{"issue":"6","key":"2172_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","volume":"24","author":"Z Walsh","year":"2013","unstructured":"Walsh Z, Callaway R, Belle-Isle L et al (2013) Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int J Drug Policy 24(6):511\u2013516","journal-title":"Int J Drug Policy"},{"issue":"21","key":"2172_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70384","volume":"13","author":"A Baral","year":"2024","unstructured":"Baral A, Diggs BNA, Marrakchi El Fellah R et al (2024) Cannabis use among cancer patients during active treatment: findings from a study at an NCI\u2010designated cancer center. Cancer Med 13(21):e70384","journal-title":"Cancer Med"},{"issue":"12","key":"2172_CR42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J et al (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30(12):1165\u20131180","journal-title":"J Psychopharmacol"},{"issue":"12","key":"2172_CR43","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA et al (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30(12):1181\u20131197","journal-title":"J Psychopharmacol"},{"issue":"1","key":"2172_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","volume":"80","author":"JS Siegel","year":"2023","unstructured":"Siegel JS, Daily JE, Perry DA, Nicol GE (2023) Psychedelic drug legislative reform and legalization in the US. JAMA Psychiat 80(1):77\u201383","journal-title":"JAMA Psychiat"},{"key":"2172_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109399","volume":"226","author":"M Marks","year":"2023","unstructured":"Marks M (2023) The varieties of psychedelic law. Neuropharmacology 226:109399","journal-title":"Neuropharmacology"},{"issue":"1","key":"2172_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1213\/ANE.0000000000006301","volume":"138","author":"G Hong","year":"2024","unstructured":"Hong G, Sideris A, Waldman S, Stauffer J, Wu CL (2024) Legal and regulatory aspects of medical cannabis in the United States. Anesth Analg 138(1):31\u201341","journal-title":"Anesth Analg"},{"key":"2172_CR47","doi-asserted-by":"crossref","unstructured":"Penner JL (2009) Psychosocial care of patients with head and neck cancer","DOI":"10.1016\/j.soncn.2009.05.008"},{"key":"2172_CR48","unstructured":"Anderson RC, Franke KA (2004) Psychological and psychosocial implications of head and neck cancer. Internet J Mental Health"},{"key":"2172_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102631","author":"CE Low","year":"2024","unstructured":"Low CE, Loke S, Pang GE, Sim B, Yang VS (2024) Psychological outcomes in patients with rare cancers: a systematic review and meta-analysis. Eclinicalmedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102631","journal-title":"Eclinicalmedicine"},{"issue":"3","key":"2172_CR50","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3390\/curroncol29030170","volume":"29","author":"DL Rodriguez","year":"2022","unstructured":"Rodriguez DL, Vidot DC, Camacho-Rivera M, Islam JY (2022) Mental health symptoms during the COVID-19 pandemic among cancer survivors who endorse cannabis: results from the COVID-19 cannabis health study. Curr Oncol 29(3):2106\u20132118","journal-title":"Curr Oncol"},{"key":"2172_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12904-021-00883-3","volume":"20","author":"T Kebebew","year":"2021","unstructured":"Kebebew T, Mavhandu-Mudzusi AH, Mosalo A (2021) A cross-sectional assessment of symptom burden among patients with advanced cervical cancer. BMC Palliat Care 20:1\u201310","journal-title":"BMC Palliat Care"},{"issue":"1","key":"2172_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cncr.33881","volume":"128","author":"S Balachandra","year":"2022","unstructured":"Balachandra S, Eary RL, Lee R et al (2022) Substance use and mental health burden in head and neck and other cancer survivors: a national health interview survey analysis. Cancer 128(1):112\u2013121","journal-title":"Cancer"},{"key":"2172_CR53","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1158\/1538-7445.AM2023-740","volume":"83","author":"C Cao","year":"2023","unstructured":"Cao C, Wang R, Yang L, Paskett ED, Shang C (2023) Prevalence and cancer-specific patterns of cannabis use among US cancer survivors, 2016\u20132021. Cancer Res 83:740\u2013740","journal-title":"Cancer Res"},{"issue":"5","key":"2172_CR54","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/j.ijrobp.2021.12.139","volume":"112","author":"AM Williams","year":"2022","unstructured":"Williams AM, Gilbert M, Siddiqui F (2022) Cannabis use in patients with head and neck cancer and radiotherapy outcomes. Int J Radiat Oncol Biol Phys 112(5):e60\u2013e61","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"2172_CR55","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jamaoto.2018.0486","volume":"144","author":"H Zhang","year":"2018","unstructured":"Zhang H, Xie M, Archibald SD, Jackson BS, Gupta MK (2018) Association of marijuana use with psychosocial and quality of life outcomes among patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg 144(11):1017\u20131022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2172_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2023.101210","volume":"47","author":"KA Black","year":"2023","unstructured":"Black KA, Bowden S, Thompson M, Ghatage P (2023) Cannabis use in gynecologic cancer patients in a Canadian cancer center. Gynecol Oncol Rep 47:101210","journal-title":"Gynecol Oncol Rep"},{"key":"2172_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2019.100497","volume":"30","author":"EA Blake","year":"2019","unstructured":"Blake EA, Ross M, Ihenacho U et al (2019) Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies. Gynecol Oncol Rep 30:100497","journal-title":"Gynecol Oncol Rep"},{"key":"2172_CR58","unstructured":"2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions (2023). https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt42729\/2022-nsduh-method-summary-defs\/2022-nsduh-method-summary-defs-110123.htm. Accessed 20 November 2024"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02172-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:02:58Z","timestamp":1782464578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02172-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02172-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"85"}}